Connect with us

Hi, what are you looking for?

Investing

Platinum and palladium have their own unique drivers, but both are basking in gold’s glow in 2025. Of the two, platinum has been the...

Investing

Osisko Metals Incorporated (the ‘ Company ‘ or ‘ Osisko Metals ‘) ( TSX: OM,OTC:OMZNF ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased...

Investing

Group Eleven Resources Corp. (TSXV: ZNG,OTC:GRLVF) (OTCQB: GRLVF) announced today that it will be participating in the 51st Annual New Orleans Investment Conference at...

Investing

Multiple Rock Samples Returned Grades Exceeding 1,000 g/t Silver Silver47 Exploration Corp. (TSXV: AGA,OTC:AAGAF) (OTCQB: AAGAF) (‘Silver47’ or the ‘Company’) is pleased to report...

Investing

Standard Uranium Ltd. (TSXV: STND,OTC:STTDF) (OTCQB: STTDF) (FSE: 9SU0) (‘Standard Uranium’ or the ‘Company’) is pleased to announce that it has closed the final tranche (the...

Investing

Metals Focus published its annual Precious Metals Investment Focus report on Saturday (October 25). The report from the leading gold analysis firm outlines the...

Investing

International Lithium Corp. (TSXV: ILC,OTC:ILHMF) (OTCQB: ILHMF) (FSE: IAH) (the ‘Company’ or ‘ILC’) is pleased to announce, further to its announcement on September 09, 2025, that...

Investing

1911 Gold Corporation (‘1911 Gold’ or the ‘Company’) (TSXV: AUMB; OTCQB: AUMBF; FRA: 2KY) is pleased to announce the appointment of Éric Vinet as Chief Operating...

Investing

(TheNewswire) Brossard, Quebec TheNewswire – le 28 octobre 2025 CORPORATION CHARBONE (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (« CHARBONE » ou la « Société...

Investing

(TheNewswire) Brossard, Quebec TheNewswire – October 28, 2025 CHARBONE CORPORATION (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (‘ CHARBONE ‘ or the ‘ Company ‘),...

Investing

Investor Insight Cartier Resources presents a compelling gold investment opportunity, driven by a growing Abitibi resource, solid institutional support, and upcoming development milestones. Overview...

Latest

Investing

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping...